Biomica Ltd.
🇮🇱Israel
- Country
- 🇮🇱Israel
- Ownership
- Subsidiary
- Established
- 2016-02-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.biomicamed.com
A First-in-human (FIH) Combination Treatment Study With a Single Dose Level of BMC128
Phase 1
Active, not recruiting
- Conditions
- Non-small Cell Lung CancerMelanomaRenal Cell Carcinoma
- Interventions
- First Posted Date
- 2022-04-29
- Last Posted Date
- 2024-05-07
- Lead Sponsor
- Biomica Ltd.
- Target Recruit Count
- 11
- Registration Number
- NCT05354102
- Locations
- 🇮🇱
Rambam MC, Haifa, Israel
© Copyright 2025. All Rights Reserved by MedPath